Nuvation Bio Inc. financial data

Symbol
NUVB, NUVB-WT on NYSE
Industry
Pharmaceutical Preparations
Location
357 Tehama Street, Floor 3, San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Panacea Acquisition Corp (to 2/11/2021)
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.7K % -63.6%
Debt-to-equity 8.52 % +212%
Return On Equity -199 % -1422%
Return On Assets -162 % -1175%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 337M shares +53.7%
Common Stock, Shares, Outstanding 336M shares +53.6%
Entity Public Float 261B USD -44.3%
Common Stock, Value, Issued 1.36B USD +44.4%
Weighted Average Number of Shares Outstanding, Basic 274K shares +25%
Weighted Average Number of Shares Outstanding, Diluted 274K shares +25%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 727K USD
Research and Development Expense 85.2M USD +17%
General and Administrative Expense 28.2M USD -12.5%
Operating Income (Loss) -560M USD -442%
Nonoperating Income (Expense) 27.2M USD +33.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -532M USD -542%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -975M USD -1077%
Earnings Per Share, Basic -2.18 USD/shares -474%
Earnings Per Share, Diluted -2.18 USD/shares -474%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 30M USD +23.1%
Marketable Securities, Current 519M USD -12.7%
Assets, Current 565M USD -9.65%
Property, Plant and Equipment, Net 719K USD -5.89%
Operating Lease, Right-of-Use Asset 2.47M USD -38.7%
Other Assets, Noncurrent 480K USD -18.2%
Assets 572M USD -9.4%
Accounts Payable, Current 12.4M USD +422%
Accrued Liabilities, Current 23.5M USD +98.3%
Contract with Customer, Liability, Current 12.9M USD
Liabilities, Current 59M USD +266%
Contract with Customer, Liability, Noncurrent 7.94M USD
Accrued Income Taxes, Noncurrent 144K USD +28.6%
Operating Lease, Liability, Noncurrent 985K USD -61.4%
Liabilities 68.9M USD +257%
Common Stocks, Including Additional Paid in Capital 117M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.38M USD
Retained Earnings (Accumulated Deficit) -861M USD -162%
Stockholders' Equity Attributable to Parent 503M USD -17.8%
Liabilities and Equity 572M USD -9.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -15.7M USD +18.8%
Net Cash Provided by (Used in) Financing Activities 21K USD -93%
Net Cash Provided by (Used in) Investing Activities 7.54M USD
Common Stock, Shares Authorized 1.06B shares 0%
Common Stock, Shares, Issued 336M shares +53.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -8.14M USD +88.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 30M USD +23.1%
Deferred Tax Assets, Valuation Allowance 100M USD +18%
Deferred Tax Assets, Gross 101M USD +17.7%
Operating Lease, Liability 2.77M USD -38%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -528M USD -576%
Lessee, Operating Lease, Liability, to be Paid 2.93M USD -39.4%
Property, Plant and Equipment, Gross 1.38M USD +2.29%
Operating Lease, Liability, Current 1.78M USD -7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.5M USD -31.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 571K USD +7.94%
Operating Lease, Weighted Average Discount Rate, Percent 0.02 pure -72.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 159K USD -56.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 713K USD -49.6%
Deferred Tax Assets, Operating Loss Carryforwards 29.3M USD +32%
Unrecognized Tax Benefits 5.63M USD +11.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 144K USD -77.1%
Share-based Payment Arrangement, Expense 25.8M USD +24.2%
Interest Expense 132K USD